Navigation Links
India extends National TB Control Program

The Indian Cabinet Committee on Economic Affairs has approved to extend by five years the Revised National TB Control Program (RNTBC)to benefit over five million people.//

The extension of the program from Oct 1, 2005 to Sep 30, 2010 would involve an expenditure of Rs.11.56 billion ($255 million). Of this, Rs.2.82 billion would be required in the 10th Plan (2002-07) and Rs.8.73 billion in the 11th Plan (2007-12).

"The direct benefit would be the treatment of 5.32 million TB patients during the project period. Of these, at least 4.52 million patients would be cured," an official spokesperson said Friday.

"This will result in averting at least 960,000 deaths, of which 480,000 would be adults, with an economic output potential of at least Rs.14,000 per year," the official said.

At an average working life of 15 years, this would mean a national economic saving of more than Rs.100 billion.

India is estimated to account for nearly 30 percent of the global tuberculosis burden. The disease is viewed as a major health problem because of its high mortality and morbidity.

RNTCP was introduced in India through a series of pilot projects beginning in 1993. Over the years it has been gradually stepped up to cover a larger population.

In 1997, the World Bank assisted RNTCP was launched at a project cost of Rs.7.49 billion and included a World Bank component of Rs.6.05 billion.

It was targeted to cover a population of 271 million (1991 census) in 102 Short Course Chemotherapy (SCC) districts and strengthen another 203 SCC districts for introduction of RNTCP at a later stage over a period of five years.

The project was further extended up to March 2004 to cover a total population of 700 million.

-- Edited(IANS)
'"/>




Page: 1

Related medicine news :

1. Is Diabetes the Leading Cause of Kidney Failure in India
2. AIDS Disaster in India is Imminent
3. Indian Prime Minister has successful Knee Replacement Surgery
4. International community warns India on HIV situation
5. India takes on foot-and-mouth disease by vaccinating animals
6. Development of AIDS vaccine -- Chiron Corp in talks with four Indian cos
7. India to benefit from pharma companies move
8. Healthcare sector is now a multi billion-dollar industry in India
9. The World Bank funds private Hospital in India
10. Parke-Davis (India) runs into rough weather – Court orders attachment of asset
11. Indian Doctor granted US patent on organ regeneration
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/26/2017)... (PRWEB) , ... June 26, 2017 , ... Torrance dentist, ... aesthetics can be one of the most noticeable aspects of a person’s appearance. A ... not everyone is born with beautiful, balanced teeth, everyone can have the smile of ...
(Date:6/26/2017)... ... June 26, 2017 , ... Dr. Martin ... Specialists, in collaboration with the Fertility Center of California, is pleased to announce ... epidydimal sperm aspiration) and TESA (percutaneous testicular sperm extraction). These minimally invasive treatments ...
(Date:6/26/2017)... ... June 26, 2017 , ... ... recent review of government data released by the United Soybean Board. , ... Maryland’s soybean farmers have increased their productivity on less land per bushel, the ...
(Date:6/26/2017)... ... June 26, 2017 , ... LARKR™ , an innovative ... in every state across the country to join its online treatment platform. , ... therapists to reach a substantially greater number of people in need nationwide, and to ...
(Date:6/26/2017)... ... 26, 2017 , ... KICKICO , a protocol built on Ethereum for ... many catastrophic issues within funding campaigns. KICKICO developers are testing the platform, which will ... the raising of funds through the power of many - has been around for ...
Breaking Medicine News(10 mins):
(Date:6/14/2017)...  In 2016, Embodied Labs took top ... and came away with $25,000 in seed-fund investment. Embodied ... as "entering the life of another" and by the ... to medical professionals in an entirely new dimension." Building ... finalist for the Department of Education,s EdSimChallenge, where they ...
(Date:6/11/2017)... , June 10, 2017  Eli Lilly and Company ... from three Phase 3 studies of galcanezumab, an investigational ... including late-breaking data on several key secondary endpoints for ... results from these studies (EVOLVE-1, EVOLVE-2 and REGAIN) will ... annual scientific meeting in Boston . ...
(Date:6/9/2017)... and INDIANAPOLIS , June ... are living with diabetes. In a further effort to ... people affected by this condition, the International Diabetes Federation ... LLY ) have come together for the second phase ... and Systems programme (BRIDGES 2), reaffirming their commitment to ...
Breaking Medicine Technology: